MICROBIOPHARM JAPAN CO LTD
Overview
MICROBIOPHARM JAPAN CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering CALCITRIOL; DAUNORUBICIN HYDROCHLORIDE (CRUDE); DOXORUBICIN HYDROCHLORIDE; EPIRUBICIN HYDROCHLORIDE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances MICROBIOPHARM JAPAN CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
MICROBIOPHARM JAPAN CO LTD holds 4 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- EPIRUBICIN HYDROCHLORIDEActive2008-09-19
- CALCITRIOLActive2000-10-31
- DOXORUBICIN HYDROCHLORIDEActive1998-04-30
- DAUNORUBICIN HYDROCHLORIDE (CRUDE)Active1996-02-29
- PARICALCITOL, USPInactive2013-05-04
- MITOMYCINInactive1998-09-01
- (1S,3R)-1,3-BIS(TERT-BUTYLDIMETHYLSILYLOXY) ANDROST-5-EN-17-ONE (SI-HDEA)Inactive1996-07-08
FDA compliance signals
1 FDA enforcement record linked to this company.
- 4832018-03-16
Valid stability test methods
Is this MICROBIOPHARM JAPAN CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.